Přihlásit se Zaregistrujte se zdarma

Dluh/Vlastní kapitál společnosti Timber Pharmaceuticals

Jaká je hodnota metriky Dluh/Vlastní kapitál společnosti Timber Pharmaceuticals?

Hodnota metriky Dluh/Vlastní kapitál společnosti Timber Pharmaceuticals, Inc. je 0.96

Jaká je definice metriky Dluh/Vlastní kapitál?



Poměr dluhu k vlastnímu kapitálu (debt to equity ratio) udává podíl vlastního kapitálu a cizích zdrojů na financování majetku společnosti.

The debt to equity ratio is generally calculated by dividing debt by equity. The D/E ratio is also known as risk, gearing or leverage. The two components are often taken from the firm's balance sheet or statement of financial position (so-called book value), but the ratio may also be calculated using market values for both, if the company's debt and equity are publicly traded, or using a combination of book value for debt and market value for equity financially. Preferred stock can be considered part of debt or equity. Attributing preferred shares to one or the other is partially a subjective decision but will also take into account the specific features of the preferred shares. When used to calculate a company's financial leverage, the debt usually includes only the long-term debt.

Dluh/Vlastní kapitál společností v sektoru Health Care sektor na NYSE ve srovnání se společností Timber Pharmaceuticals

Čemu se věnuje společnost Timber Pharmaceuticals?

Timber Pharmaceuticals LLC, a clinical-stage biopharmaceutical dermatology company, focused on the development and commercialization of treatments for orphan dermatologic diseases. The company was founded in 2019 and is headquartered in Basking Ridge, New Jersey.

Firmy s metrikou dluh/vlastní kapitál podobnou společnosti Timber Pharmaceuticals